NEW YORK: The GCI Group has promoted Michael Roth to SVP,

healthcare practice. Previously, Roth was in charge of the Forest

Laboratories account, where he managed PR for Forest's antidepressant

drug Celexa, as well as Forest's interactive work. Roth's PR background

includes experience across a wide range of medical fields, including

sleep disorders, central nervous system diseases, chronic pain

management, cardiology, ophthalmology, oncology, and antiherpetics.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in